Health Condition 1: L21- Seborrheic dermatitis
Conditions
Interventions
Intervention1: Individualized homeopathic medicines in individualized dosage plus concomitant care: The intervention involves administering indicated homeopathic medicines in centesimal potencies (CH)
Sponsors
D N De Homoeopathic Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients suffering from seborrheic dermatitis. The diagnosis will be based upon recognizing folliculocentric lesions or erythematous plaques with yellow, greasy scales, and their typical distribution in seborrheic areas. 2. Age between 18 and 65 years. 3. Participants of either sex or transgender. 4. Patient’s ability to understand English/ Hindi/ Bengali. 5. Diagnosed cases of mild and moderate seborrheic dermatitis (ICD 11- EA81) (For scalp: EA81.1, For face: EA81.0) as per International Classification of Diseases for Mortality and Morbidity Statistics, 11th Revision, v2024-01. 6. Patients not taking any allopathic treatment or using topical agents for seborrheic dermatitis from past 2 weeks will be included in the study.
Exclusion criteria
Exclusion criteria: 1. Not providing with written informed consent of participation. 2. Patients suffering from severe form of seborrheic dermatitis or having super-added bacterial or candidal infection. 3. Patients who are too sick for consultation. 4. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled systemic illness or life-threatening condition, affecting quality of life. 5. Pregnancy, puerperal women and lactating mothers 6. Tobacco chewing and/or smoking, alcoholism and/or any form(s) of substance abuse and/or dependence (TAPS tool). 7. Self-reported immune-compromised state, AIDS, hepatitis etc. 8. Undergoing homoeopathic treatment for any chronic disease within last 3 months. 9. Simultaneous participation in any other clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Scalpdex: A quality of life instrument for scalp dermatitisTimepoint: Baseline, and every month, up to 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| SEborrheic Dermatitis Area and Severity Index (SEDASI)Timepoint: Baseline, and every month, up to 3 months;Measure Yourself Medical Outcome Profile v.2 (MYMOP-2)Timepoint: Baseline, and every month, up to 3 months | — |
Countries
India
Contacts
Public ContactSumana Sengupta
D N De Homoeopathic Medical College and Hospital
Outcome results
None listed